Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $184.6 million.

  • Bio-Techne's Receivables - Net fell 1529.14% to $184.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $184.6 million, marking a year-over-year decrease of 1529.14%. This contributed to the annual value of $206.9 million for FY2025, which is 1429.94% down from last year.
  • As of Q4 2025, Bio-Techne's Receivables - Net stood at $184.6 million, which was down 1529.14% from $183.9 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Receivables - Net ranged from a high of $241.4 million in Q2 2024 and a low of $145.4 million during Q2 2021
  • For the 5-year period, Bio-Techne's Receivables - Net averaged around $196.5 million, with its median value being $203.3 million (2022).
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 3434.42% in 2021, then plummeted by 1778.86% in 2025.
  • Quarter analysis of 5 years shows Bio-Techne's Receivables - Net stood at $152.9 million in 2021, then rose by 20.84% to $184.8 million in 2022, then grew by 12.28% to $207.5 million in 2023, then increased by 5.06% to $217.9 million in 2024, then fell by 15.29% to $184.6 million in 2025.
  • Its last three reported values are $184.6 million in Q4 2025, $183.9 million for Q3 2025, and $206.9 million during Q2 2025.